Literature DB >> 10409432

Comparative analysis of a novel gene from the Wolf-Hirschhorn/Pitt-Rogers-Danks syndrome critical region.

T J Wright1, J L Costa, C Naranjo, P Francis-West, M R Altherr.   

Abstract

Wolf-Hirschhorn syndrome (WHS) is a multiple malformation syndrome characterized by mental and developmental defects resulting from the absence of a segment of one chromosome 4 short arm (4p16.3). Recently, Pitt-Rogers-Danks syndrome (PRDS), which is also due to a deletion of chromosome 4p16.3, has been shown to be allelic to WHS. Due to the complex and variable expression of these disorders, it is thought that WHS/PRDS results from a segmental aneusomy of 4p resulting in haploinsufficieny of an undefined number of genes that contribute to the phenotype. In an effort to identify genes that contribute to human development and whose absence may contribute to the phenotype associated with these syndromes, we have generated a transcript map of the 165-kb critical region and have identified a number of potential genes. One of these genes, WHSC2, which was identified with the IMAGE cDNA clone 53283, has been characterized. Sequence analysis defined an open reading frame of 1584 bp (528 amino acids), and transcript analysis detected a 2.4-kb transcript in all fetal and adult tissues tested. In parallel, the mouse homologue was isolated and characterized. Mouse sequence analysis and the pattern of expression are consistent with the clone being the murine equivalent of the human WHSC2 gene (designated Whsc2h). The data from sequence and transcript analysis of this new human gene in combination with the lack of significant similarity to proteins of known function imply that it represents a novel gene. Most importantly, its location within the WHSCR suggests that this gene may play a role in the phenotype of the Wolf-Hirschhorn/Pitt-Rogers-Danks syndrome. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409432     DOI: 10.1006/geno.1999.5871

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  Acute NelfA knockdown restricts compensatory gene expression and precipitates ventricular dysfunction during cardiac hypertrophy.

Authors:  Saleena Alikunju; Elena Severinova; Zhi Yang; Andreas Ivessa; Danish Sayed
Journal:  J Mol Cell Cardiol       Date:  2020-04-09       Impact factor: 5.000

2.  Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.

Authors:  Jonathan J Keats; Christopher A Maxwell; Brian J Taylor; Michael J Hendzel; Marta Chesi; P Leif Bergsagel; Loree M Larratt; Michael J Mant; Tony Reiman; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

3.  Wolf-Hirschhorn Syndrome: Clinical and Genetic Data from a First Case Diagnosed in Central Africa.

Authors:  Sébastien Mbuyi-Musanzayi; Aimé Lumaka; Toni Lubala Kasole; Erick Kasamba Ilunga; Bienvenu Yogolelo Asani; Prosper Lukusa Tshilobo; Prosper Kalenga Muenze; Hervé Reychler; François Tshilombo Katombe; Koenraad Devriendt
Journal:  J Pediatr Genet       Date:  2017-03-07

4.  Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA.

Authors:  Yuki Yamaguchi; Naoto Inukai; Takashi Narita; Tadashi Wada; Hiroshi Handa
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

5.  Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex.

Authors:  Takashi Narita; Yuki Yamaguchi; Keiichi Yano; Seiji Sugimoto; Sittinan Chanarat; Tadashi Wada; Dong-ki Kim; Jun Hasegawa; Masashi Omori; Naoto Inukai; Masaki Endoh; Tomoko Yamada; Hiroshi Handa
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

6.  NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly.

Authors:  Daniel A Gilchrist; Sergei Nechaev; Chanhyo Lee; Saikat Kumar B Ghosh; Jennifer B Collins; Leping Li; David S Gilmour; Karen Adelman
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

7.  Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn Syndrome.

Authors:  Erica F Andersen; John C Carey; Dawn L Earl; Deyanira Corzo; Michael Suttie; Peter Hammond; Sarah T South
Journal:  Eur J Hum Genet       Date:  2013-08-21       Impact factor: 4.246

8.  An in situ hybridization-based screen for heterogeneously expressed genes in mouse ES cells.

Authors:  Mark G Carter; Carole A Stagg; Geppino Falco; Toshiyuki Yoshikawa; Uwem C Bassey; Kazuhiro Aiba; Lioudmila V Sharova; Nabeebi Shaik; Minoru S H Ko
Journal:  Gene Expr Patterns       Date:  2007-11-04       Impact factor: 1.224

9.  Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2.

Authors:  Marcella Zollino; Rosetta Lecce; Rita Fischetto; Marina Murdolo; Francesca Faravelli; Angelo Selicorni; Cinzia Buttè; Luigi Memo; Giuseppe Capovilla; Giovanni Neri
Journal:  Am J Hum Genet       Date:  2003-01-30       Impact factor: 11.025

10.  Prenatal diagnosis of Wolf-Hirschhorn syndrome confirmed by comparative genomic hybridization array: report of two cases and review of the literature.

Authors:  Stavros Sifakis; Emmanouil Manolakos; Annalisa Vetro; Dimitra Kappou; Panagiotis Peitsidis; Maria Kontodiou; Antonios Garas; Nikolaos Vrachnis; Anastasia Konstandinidou; Orsetta Zuffardi; Sandro Orru; Ioannis Papoulidis
Journal:  Mol Cytogenet       Date:  2012-02-28       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.